生物
病毒学
细胞毒性T细胞
乙型肝炎病毒
CD8型
病毒
表位
免疫疗法
免疫学
病毒复制
病毒载量
T细胞
乙型肝炎
免疫系统
抗体
体外
生物化学
作者
George Webster,Stephanie Reignat,David J. Brown,Graham S. Ogg,Louise Jones,Suranjith L. Seneviratne,Roger Williams,Geoffrey Dusheiko,Antonio Bertoletti
出处
期刊:Journal of Virology
[American Society for Microbiology]
日期:2004-05-12
卷期号:78 (11): 5707-5719
被引量:387
标识
DOI:10.1128/jvi.78.11.5707-5719.2004
摘要
ABSTRACT The cytotoxic T-cell response in chronic hepatitis B virus (HBV) infection has been described as weak and mono- or oligospecific in comparison to the more robust virus-specific T-cell response present in resolved infection. However, chronic hepatitis B is a heterogeneous disease with markedly variable levels of virus replication and liver disease activity. Here we analyzed (both directly ex vivo and after in vitro stimulation) the HBV-specific CD8 T-cell responses against structural and nonstructural HBV proteins longitudinally in patients with different patterns of chronic infections. We found that the profiles of virus-specific CD8 + -T-cell responses during chronic infections are highly heterogeneous and influenced more by the level of HBV replication than by the activity of liver disease. An HBV DNA load of <10 7 copies/ml appears to be the threshold below which circulating multispecific HBV-specific CD8 + T cells are consistently detected. Furthermore, CD8 + T cells with different specificities are differentially regulated during chronic infections. HBV core-specific CD8 + T cells are associated with viral control, while CD8 + T cells specific for envelope and polymerase epitopes can occasionally be found in the setting of high levels (>10 7 copies) of HBV replication. These findings have implications for the design of immunotherapy for chronic HBV infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI